Spec-T Side effects

• Side effects of Spec-T in details
• Spec-T contraindications
• Spec-T reviews

What are the possible side effects of Spec-T?

Spec-T used in the mouth may cause a condition in which the oxygen in your body tissues can become dangerously low. This is a potentially fatal condition called methemoglobinemia (met-HEEM-oh glo-bin-EE-mee-a). This condition may occur after only one use of benzocaine or after several uses.

Signs and symptoms may occur within minutes or up to 2 hours after using Spec-T in the mouth or throat. GET EMERGENCY MEDICAL HELP IF YOU HAVE:

• a headache, tiredness, confusion;

• fast heartbeats;

• feeling light-headed or short of breath; and

• pale, blue, or gray appearance of your skin, lips, or fingernails.

Get emergency medical help if you have signs of an allergic reaction to Anbesol: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using Spec-T and call your doctor at once if you have:

• severe burning, stinging, or sensitivity where the medicine is applied;

• swelling, warmth, or redness; or

• oozing, blistering, or any signs of infection.

Common Spec-T side effects may include:

• mild stinging, burning, or itching where the medicine is applied;

• skin tenderness or redness; or

• dry white flakes where the medicine was applied.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Side effects of Spec-T in details

Applies to Spec-T: cream, film, gel/jelly, lotion, lozenge/troche, ointment, paste, powder for suspension, solution, spray, swab, tablet disintegrating

Other dosage forms:

• topical application gel/jelly, topical application liquid, topical application ointment, topical application solution, topical application spray

Along with its needed effects, Spec-T (the active ingredient contained in Spec-T) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking Spec-T:

Incidence Not Known

• Bluish-colored lips, fingernails, or palms
• dark urine
• difficulty breathing
• dizziness or lightheadedness
• headache
• high fever
• nausea
• pale skin
• rapid heart rate
• sore throat
• unusual bleeding or bruising
• unusual tiredness or weakness
• vomiting
• worsening of pain, redness, swelling, or irritation in or around the mouth

What is the most important information I should know about Spec-T?

• Do not use Spec-T on severe burns or deep puncture wounds.
• If your symptoms do not improve within 7 days or if they become worse, check with your doctor.
• Do not exceed the recommended dose or use Spec-T for longer than 7 days without checking with your doctor.
• Spec-T is extremely flammable. Do not store or use near an open flame or while smoking.
• The contents of this container are under pressure. Do not burn or puncture the container, even if it appears to be empty.
• Do not inhale the contents of this container. Inhaling the contents of this container may be harmful or fatal.
• Use of Spec-T is not recommended in CHILDREN younger than 2 years of age without first checking with your doctor. Safety and effectiveness have not been established.
• PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Spec-T, discuss with your doctor the benefits and risks of using Spec-T during pregnancy. It is unknown if Spec-T is excreted in breast milk. If you are or will be breast-feeding while you are using Spec-T, check with your doctor or pharmacist to discuss the risks to your baby.

Spec-T contraindications

If you have any of these other conditions, you may need a dose adjustment or special tests to safely use Spec-T:

asthma, bronchitis, emphysema, or other breathing disorder;

heart disease;

a personal or family history of methemoglobinemia, or any genetic enzyme deficiency; or

if you smoke.

References

1. DailyMed. "DEXTROMETHORPHAN HYDROBROMIDE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
2. DTP/NCI. "benzocaine: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
3. European Chemicals Agency - ECHA. "Levomethorphan: The information provided here is aggregated from the "Notified classification and labelling" from ECHA's C&L Inventory. ". https://echa.europa.eu/information-o... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Spec-T are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Spec-T. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name:  Email:  Spam protection:  < Type 21 here

Information checked by Dr. Sachin Kumar, MD Pharmacology